Q3 Results: How did 5 key sectors perform during the quarter?

Q3 Results: How did 5 key sectors perform during the quarter?

As the results for the Oct-Dec quarter are unveiled, insights from management commentaries across various sectors provide valuable indicators of the Indian economy’s health. Businesses serve as the backbone of the economy, and their performance reflects the overall economic landscape. By examining key sectors and their respective performances, we aim to share a comprehensive overview … Read more

Looking for hidden gems? Look into these 3 sectors: Anshul Saigal

Looking for hidden gems? Look into these 3 sectors: Anshul Saigal

Anshul Saigal, Founder, Saigal Capital, says “one should really focus on bottom-up opportunities, not worry about the market levels, market direction. As long as we have got good companies at reasonable valuations in our portfolios, over the long term, we will be very well-placed. And there is a lot of money to be made in … Read more

Blockchain in Pharma Unleashes a New Era of Trust and Efficiency – ET HealthWorld

Blockchain in Pharma Unleashes a New Era of Trust and Efficiency – ET HealthWorld

In the ever-evolving landscape of pharmaceuticals, where precision, safety, and trust are non-negotiable, blockchain technology emerges as the beacon of a revolutionary transformation. Beyond its cryptocurrency origins, blockchain is poised to redefine lifescience businesses, reshaping processes from the laboratory to the global supply chain. As per a Gartner report, blockchain’s business value in the pharmaceutical … Read more

Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%

Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%

There was a time when having MNC stock was a must have in one’s portfolio. They reason, they were very liberal at giving bonuses, dividend payments were good and given the fact some of them actually owned the best of the brands, they had seen a secular growth, which meant they were also able to … Read more

Sun Pharma moves Madras High Court challenging a 1998 G.O. declaring places within 5 km radius from Vedanthangal lake also to be a sanctuary

Sun Pharma moves Madras High Court challenging a 1998 G.O. declaring places within 5 km radius from Vedanthangal lake also to be a sanctuary

Sun Pharmaceutical Industries Limited has moved to the Madras High Court with a plea to quash a 1998 Government Order (G.O.) through which not only the 73.06 acre Vedanthangal Lake but also all places within the 5km radius around it were declared a bird sanctuary. Chief Justice S.V. Gangapurwala and Justice P.D. Audikesavalu on Monday … Read more

How Medical Commission’s generics push may impact companies

How Medical Commission’s generics push may impact companies

ET Intelligence Group: If the diktat of the National Medical Commission (NMC) mandating doctors to prescribe only generic drugs indeed gets implemented, drug marketing in India is likely to witness five major changes.1. Companies with not-so-strong brands are likely to face the heat.Mid-sized pharma companies having brands that are not in top-ten in their therapies … Read more

ETMarkets Smart Talk- We expect IT and pharma to do well amid attractive valuations: Kedar Kadam

ETMarkets Smart Talk- We expect IT and pharma to do well amid attractive valuations: Kedar Kadam

“We expect yesterday’s underperformers to be winners of tomorrow, i.e. IT and Pharma. The valuations are very attractive from a long-term investment perspective despite short-term risks to earnings,” says Kedar Kadam, Director – Listed Investments at Waterfield Advisors. In an interview with ETMarkets, Kadam said: “We like Capital goods, Cement, Speciality chemicals, Auto ancillaries and … Read more

Pharma good for next 2-3 years; wait a quarter before entering IT: Abhishek Basumallick

Pharma good for next 2-3 years; wait a quarter before entering IT: Abhishek Basumallick

Abhishek Basumallick, Chief Investment Adviser, Intelsense Capital, says “the problem with IT, especially IT services, is that until and unless there is very clear visibility of growth in the US market, the buyers or the clients do not tend to go and start giving new projects. They have always been cautious in giving out new … Read more

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

Suven Pharmaceuticals Limited is a company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations. Synopsis Pharma as a sector has been under pressure for a very long time. However, … Read more

Two hospitals, pharma company hit by ransomware attack in a month – ET HealthWorld

Two hospitals, pharma company hit by ransomware attack in a month – ET HealthWorld

Ahemdabad: When a team of experts from the National Forensic Sciences University (NFSU) checked the logs of the ransomware files at a city hospital after a cyberattack, they were surprised – the execution of the file, which took place at 2am, had been sitting pretty in the system since March! “The latest attack was found … Read more